Posted in | News | Quantum Physics

Berkeley Lab Physics Division Director Testifies on Future of Particle Physics

On June 10th in Washington D.C. Natalie Roe, Director of the Physics Division at Berkeley Lab, testified at a congressional subcommittee hearing on the future of particle physics, prompted by the recent release of the Particle Physics Project Prioritization report.

 

Berkeley Lab Physics Division Director Natalie Roe testifies before the United States House Committee on Science Science Subcommittee on Energy

 

In addition to detailing the excitement of particle physics’ past and present, Roe presented a case for its bright future, all the while focusing on the importance of small-scale experiments that deliver groundbreaking discoveries. She also spoke of the mystery of dark energy—an unexplained force that appears to be accelerating the expansion of the universe—and outlined an exciting new effort called the Dark Energy Spectroscopic Instrument, or DESI, a small-scale project to be managed by Berkeley Lab.

You can read Roe’s written testimony here.

It’s been a busy month for Roe. On June 6th, she participated in a panel discussion at the Large Hadron Collider Physics Conference, hosted by Brookhaven National Laboratory and Columbia University. Called “The Road to Discovery” and moderated by New York Times reporter Dennis Overbye, the discussion gave Roe and other experts a chance to detail the future of collider-based particle physics research and potential forthcoming discoveries.

You can read a summary of the LHCP Conference panel discussion in Symmetry Magazine here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.